Drug induced aseptic meningitis: Difference between revisions
No edit summary |
|||
| Line 33: | Line 33: | ||
**[[Methylprednisolone acetate]] | **[[Methylprednisolone acetate]] | ||
**[[Allopurinol]] | **[[Allopurinol]] | ||
==Clinical presentation== | |||
==Clinical presentation== | |||
*[[Headache]] | *[[Headache]] | ||
*[[Fever]] | *[[Fever]] | ||
| Line 53: | Line 54: | ||
**Requires informed written consent | **Requires informed written consent | ||
**Due to associated risk, should only be done if suspected drug is irreplaceable | **Due to associated risk, should only be done if suspected drug is irreplaceable | ||
==Treatment== | |||
*Discontinuation of offending agent | |||
==References== | |||
Moris, G, Garcia-Monco, JC. The challenge of drug-induced aseptic meningitis. Arch intern med. 1999 Jun 14; 159 (11): 1185-94 | |||
Nettis, E, Calogiuri, G, Colanardi, MC, Ferrannini, A, Tursi, A. Drug-induced aseptic meningitis. Current Drug Targets - Immune, Endocrine & Metabolic Disorders, 2003, 3, pp. 143-149 | |||
Revision as of 19:39, 1 September 2017
Background
- Abbreviation: DIAM
- Two proposed mechanisms
- Direct meningeal irritation by intrathecal drug
- Hypersensitivity reaction to drug (type III and IV)
- Higher predominance in SLE and female gender
Causes
- NSAIDs
- Most common cause
- Antibiotics
- Immunoregulating agents
- IVIGs
- OKT3 monoclonal antibodies
- Misc
Clinical presentation
- Headache
- Fever
- Nuchal rigidity
- Nausea/vomiting
- General malaise
- Altered mental status
- Less common symptoms include rash, arthralgia, myalgia, facial edema
Diagnosis
- Drug history with focus on time of ingestion and symptom onset
- CSF studies
- Pleiocytosis (primarily neutrophilic)
- Elevated protein levels
- Normal glucose
- Negative cultures
- Challenge test with suspected drug
- Only confirmatory test
- Requires informed written consent
- Due to associated risk, should only be done if suspected drug is irreplaceable
Treatment
- Discontinuation of offending agent
References
Moris, G, Garcia-Monco, JC. The challenge of drug-induced aseptic meningitis. Arch intern med. 1999 Jun 14; 159 (11): 1185-94 Nettis, E, Calogiuri, G, Colanardi, MC, Ferrannini, A, Tursi, A. Drug-induced aseptic meningitis. Current Drug Targets - Immune, Endocrine & Metabolic Disorders, 2003, 3, pp. 143-149